Brief: Mithra Pharmaceuticals Announces Approval Of Oral Contraceptive Estelle In Russia
16/09/2021 06:41
Sept 16 (Reuters) - MITHRA PHARMACEUTICALS SA MITRA.BR :
* ANNOUNCES ESTELLE APPROVAL IN RUSSIA
* RUSSIAN MEDICINES AGENCY HAS APPROVED REGISTRATION
APPLICATION
FOR NOVEL COMBINED ORAL CONTRACEPTIVE ESTELLE
Source text: https://bit.ly/3keZ8I5
Further company coverage: MITRA.BR
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Mithra Pharmaceuticals SA
See all newsBrief: Mithra Sells Estetra, Neuralis, Specific Assets To Gedeon Richter for EUR 175 Mln
Brief: Mithra Receives Additional EUR 2.5 Million To Advance Monetization
Brief: Mithra Secures Court Protection Measures To Advance Monetization Process
Brief: Mithra Pharmaceuticals Achieves LPR In Estetrol Skin Study
Brief: Mithra Applies To Liege Company Court For A "Transfer Under Judicial Supervision" For Mithra CDMO